Europe Smoking Cessation and Nicotine De-Addiction Market is expected to grow with the CAGR of 25.3% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Europe smoking cessation and nicotine de-addiction market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Europe smoking cessation and nicotine de-addiction market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
Imperial Brands is dominating the market and the other players in the market are Cipla Inc., Johnson & Johnson Services, Inc., Takeda Consumer Healthcare Company Limited, Alkalon A/S, 22nd Century Group, Inc., GlaxoSmithKline plc., Imperial Brands, Japan Tobacco Inc., British American Tobacco, Perrigo Company plc, Fertin Pharma, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd., Pfizer Inc. and Strides Pharma Science Limited among others.
Imperial Brands founded in 1901 headquartered in Bristol, U.K. as public ownership. The company is engaged in the manufacturing of providing fast moving consumer goods borne out of a strong tobacco. The company have product category which are new generation products. The company has wide global presence across the U.K., Germany, France, and U.S.
Pfizer Inc., founded in 1849 headquartered in New York, U.S.as public ownership. The company is engaged in the manufacturing of wide range of health care products including innovative medicines and vaccines. The company offers wide range of product categories such as Abrilada Injection, Accupril, Accuretic, Acetylcysteine, Adenosine, Aldactazide, and among many others under which the market focused category is Nicotrol Inhaler. The company has presence in a North America, South America, Europe, Asia-Pacific, Middle East and Africa.
Dr. Reddy Laboratories Ltd.
Dr. Reddy Laboratories Ltd. founded in 1984, is headquartered in Telangana, India as public ownership. The company is engaged in manufacturing and marketing the pharmaceutical products. The company has product category such as Habitrol and Habitrol is market focused segment. The company has wide global presence in Europe, Asia-Pacific, Americas and South Africa.
Asia-Pacific Smoking Cessation and Nicotine De-Addictions Market – Industry Trends and Forecast to 2027
Europe Smoking Cessation and Nicotine De-Addiction Market - Industry Trends and Forecast to 2028
Middle East and Africa Smoking Cessation and Nicotine De-Addictions Market – Industry Trends and Forecast to 2027
North America Smoking Cessation and Nicotine De-Addictions Market – Industry Trends and Forecast to 2029